Search clinical trials for: sNN0031

Total 11 results

Newron Sweden AB

Terminated

A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.

Parkinson's Disease

Sweden
Newron Sweden AB
Quintiles, Inc.; Medtronic

Completed

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Parkinson's Disease

Sweden
Newron Sweden AB
Medtronic; ICON Clinical Research

Completed

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Belgium
Newron Sweden AB
Medtronic; ICON Clinical Research

Terminated

An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Belgium
Newron Sweden AB

Terminated

A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Synairgen Research Ltd.

Completed

Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection

SARS-CoV-2

United Kingdom
Newron Sweden AB

Terminated

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Synairgen Research Ltd.

Completed

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 (SPRINTER)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
Newron Sweden AB
European Union

Terminated

Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD

Parkinson's Disease

United Kingdom, Sweden, Germany
Synairgen Research Ltd.

Completed

A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaborators

Completed

ACTIV-2: A Study for Outpatients With COVID-19

Covid19 | Coronavirus

United States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada

Search clinical trials for: sNN0031

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations